Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides

Area of Science:

• Microbiology
• Infectious Diseases
• Biochemistry

Background:

• Pythium insidiosum causes difficult-to-treat infections in both humans and animals.
• Antimicrobial peptides (AMPs) are a crucial part of the innate immune system.
• Exploring novel therapeutic agents against P. insidiosum is essential.

Purpose of the Study:

• To evaluate the in vitro anti-Pythium insidiosum activity of three specific AMPs: MSI-78, LL-37, and magainin-2.
• To determine the minimum inhibitory concentration (MIC) of these AMPs against clinical isolates of P. insidiosum.

Main Methods:

• The CLSI M38-A2 protocol was followed to determine the MIC.
• Fourteen clinical strains of Pythium insidiosum were incubated with varying concentrations of MSI-78, LL-37, and magainin-2.
• Antimicrobial activity was assessed by observing growth inhibition.

Main Results:

• All three tested AMPs (MSI-78, LL-37, and magainin-2) demonstrated significant antimicrobial activity against all fourteen clinical strains of P. insidiosum.
• The minimum inhibitory concentration (MIC) range for the AMPs was found to be 20-80 mg/L.
• The peptides successfully inhibited the growth of P. insidiosum in vitro.

Conclusions:

• The evaluated AMPs exhibit potent anti-Pythium insidiosum activity.
• MSI-78, LL-37, and magainin-2 represent promising candidates for the development of new treatments against P. insidiosum infections.
• Further research into the therapeutic potential of these AMPs is warranted.